Founders Financial Alliance’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-663
Closed -$289K 559
2025
Q1
$289K Buy
+663
New +$266K 0.07% 264
2024
Q4
Sell
-511
Closed -$266K 583
2024
Q3
$266K Hold
511
0.07% 238
2024
Q2
$277K Sell
511
-9
-2% -$4.76K 0.08% 221
2024
Q1
$270K Sell
520
-63
-11% -$31.3K 0.08% 219
2023
Q4
$275K Buy
583
+54
+10% +$25K 0.11% 193
2023
Q3
$230K Sell
529
-14
-3% -$6.35K 0.1% 199
2023
Q2
$241K Buy
+543
New +$250K 0.09% 224
2023
Q1
Sell
-556
Closed -$285K 465
2022
Q4
$285K Hold
556
0.13% 168
2022
Q3
$252K Sell
556
-63
-10% -$30.1K 0.13% 176
2022
Q2
$299K Sell
619
-360
-37% -$178K 0.15% 153
2022
Q1
$481K Sell
979
-1
-0.1% -$457 0.21% 108
2021
Q4
$454K Sell
980
-9
-0.9% -$3.79K 0.18% 122
2021
Q3
$369K Buy
989
+157
+19% +$59.7K 0.17% 136
2021
Q2
$319K Buy
832
+37
+5% +$14.1K 0.15% 161
2021
Q1
$317K Buy
795
+148
+23% +$47.6K 0.16% 149
2020
Q4
$208K Buy
647
+595
+1,144% +$183K 0.12% 187
2020
Q3
$14K Buy
+52
New +$14K 0.01% 668

Other funds holding ELV

Founders Financial Alliance's ELV Position: Q2 2025 in Review

Founders Financial Alliance sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 663 shares — an estimated $289K sold.

Founders Financial Alliance first reported a position in ELV in Q3 2020 and held it in 17 quarters. The position peaked at $481K in Q1 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Founders Financial Alliance reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Founders Financial Alliance sold 663 Elevance Health shares in Q2 2025, an estimated $289K.
  • Founders Financial Alliance first reported a position in Elevance Health in Q3 2020 and held it in 17 quarters.
  • Founders Financial Alliance's Elevance Health position peaked at $481K in Q1 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Founders Financial Alliance's 13F filing for Q2 2025, filed 12 Aug 2025.